Liabilities / Assets
83rd percentile
Higher debt load relative to assets than 83% of similar nonprofits.
990 • Fiscal year 2013 • EIN 45-2191464
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
83rd percentile
Higher debt load relative to assets than 83% of similar nonprofits.
Liabilities / Revenue
87th percentile
Higher debt load relative to revenue than 87% of similar nonprofits.
Net Margin
22nd percentile
Higher net margin than 22% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
33rd percentile
Faster asset growth than 33% of similar nonprofits.
Revenue Growth
88th percentile
Faster revenue growth than 88% of similar nonprofits.
Assets
Down$332,064
Down $23,438 (-6.6%) from 2012
Net Assets
Down$250,792
Down $52,910 (-17%) from 2012
Liabilities
Up$81,272
Up $29,472 (+57%) from 2012
Revenue
$357,179
No earlier filing loaded for comparison.
Expenses
Up$397,480
Up $190,650 (+92%) from 2012
Net Income
-$40,301
No earlier filing loaded for comparison.
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To conduct research on the etiology, pathogenesis, biomarkers, and treatment of myalgic encephelomyelitis (me) formerly know as chronic fatigue syndrome (cfs). Our mission statement is to scientifically redefine me/cfs.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.